RoslinCT is a leading Cell Therapy Contract Development and Manufacturing Organisation (CDMO) enabling you to bring your autologous or allogeneic therapy safely to the patient.

We translate and develop your cell and gene therapy research into robust cGMP qualified processes through our experience and expertise.

Bringing cell therapy products to the market
RoslinCT offers a range of integrated services from GMP translation of research protocols, analytical assay development and process development through to GMP manufacturing and QP batch release of cell-based therapies for clinical trials and commercialisation.

Originally founded in 2006 as a spin-out from the Roslin Institute, we built on the broad range of scientific expertise available in the field of cell biology. Based at both the Edinburgh BioQuarter and Edinburgh Technopole, we operate a fully licensed GMP manufacturing facility and have a proven track record in the delivery of cell-based products.